Dermatology: Recent Episodes
ReachMD
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Steven R. Feldman, MD, PhD
Patients’ adherence to psoriasis treatment, especially topical treatment, is often abysmal due to a variety of challenges and factors. That’s why Dr. Charles Turck speaks with Dr. Steven Feldman about these common challenges and how we can overcome them to improve adherence among our psoriasis patients. Dr. Feldman is a Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in Winston Salem, North Carolina.
Host: Raj Chovatiya, MD, PhD
Guest: Tina Bhutani, MD, MAS
Oftentimes patients with skin of color are diagnosed with psoriasis at a later stage than Caucasian patients. There are also disparities in access to treatment and education. According to a recent study, some patients with skin of color were less willing to use certain medications to treat their psoriasis. To learn more, join Dr. Raj Chovatiya and Dr. Tina Bhutani, Associate Adjunct Professor of Dermatology at the University of California San Francisco School of Medicine and Owner of Synergy Dermatology in San Francisco.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Amy McMichael, MD
A recent study that looked at psoriasis in patients from different races and backgrounds found that there weren’t a significant number of differences in the factors studied between patients with skin of color and Caucasian patients. The one thing that was really quite impactful for patients who are Black is that they wanted to see more physicians who could speak to their cultural and ethnic backgrounds. So to learn more about the findings and how we can address these barriers, join Dr. Charles Turck as he dives in with Dr. Amy McMichael, Professor in the Department of Dermatology at Wake Forest School of Medicine in Winston-Salem, North Carolina.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Taylor Dickerson, MD
According to a recent study, patients with skin of color waited three times longer to be formally diagnosed with psoriasis and were almost four times more likely to be biopsied compared to non-Hispanic patients. And as a result, these patients were more likely to present with severe disease, greatly impacting their overall quality of life. To learn more about this study’s findings and how we can address racial disparities in psoriasis care, Dr. Charles Turck speaks with lead author Dr. Taylor Dickerson. Dr. Dickerson is a board-certified dermatologist and micrographic dermatologic surgeon at U.S. Dermatology Partners in Texas.
Guest: Andres Yarur, MD
It’s not uncommon for patients with inflammatory bowel disease (IBD) to have an overlapping immune-mediated condition like psoriasis, which is why it’s important to tailor therapy for these patients. Here to discuss the link between psoriasis and IBD and how this can affect our management approach is Dr. Andres Yarur, Associate Professor of Medicine at Cedars Sinai Medical Center in Los Angeles, California.
Host: Raj Chovatiya, MD, PhD
Guest: Steven R. Feldman, MD, PhD
According to recent studies, only about 50 percent of psoriasis patients are adherent to topical medications by the end of an eight-week treatment period. This can have a significant impact on a patient’s overall quality of life and outcomes, which is why Dr. Raj Chovatiya speaks with Dr. Steven Feldman about strategies to improve psoriasis patients’ adherence to topical agents. Dr. Feldman is a Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in Winston-Salem, North Carolina
Guest: John Barbieri, MD, MBA, FAAD
Patients with psoriasis die about five years younger than those without the condition, and cardiovascular disease is the leading cause of this premature mortality. Tune in to hear Dr. John Barbieri discuss strategies to identify risk factors and improve cardiovascular disease prevention in patients with psoriasis. Dr. Barbieri is an Assistant Professor of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston.
Host: Raj Chovatiya, MD, PhD
Guest: Jason E. Hawkes, MD, MS, FAAD
There are a few key points that dermatologists need to keep at the forefront of conversations to help bridge education gaps around psoriasis. One is to try and eliminate burdens that are deterring practitioners in dermatology from using highly effective and very safe medications. To learn more on how we can have a positive impact on education gaps and advocacy, join Dr. Raj Chovatiya as he speaks with Dr. Jason Hawkes, Medical Dermatologist in Sacramento, California.
Guest: Shari Lipner, MD
A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of emerging treatments for different dermatological diseases, which have also shown differential biologic treatments based on race. To learn about the findings and how we can help fill this gap, join Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine and co-author of the article, titled Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients, which was published in the Journal of Drugs in Dermatology in July 2023.
Host: Sapna Patel, MD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Sapna Patel, MD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Jeffrey S. Weber, MD, PhD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Mario E. Lacouture, MD
Host: Sapna Patel, MD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Mario E. Lacouture, MD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Jeffrey S. Weber, MD, PhD
This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Host: Meghan Mooradian, MD
This Patient Clinician Connection CME activity, led by Dr. Meghan Mooradian, focuses on the use of adjuvant immunotherapy in early-stage melanoma. The activity aims to educate clinicians on the role of immunotherapy in reducing the risk of disease recurrence post-surgery, particularly in patients with resected stage IIB to III melanoma. Through patient clinical vignettes and audience education vignettes, participants will gain insights into patient-centered approaches, shared decision-making, and the management of immune-related adverse events associated with adjuvant immunotherapy, ultimately enhancing their ability to optimize treatment outcomes and patient care in this setting.
Guest: Terry Faleye, MPAS, PA-C
Guest: Jonathan I. Silverberg, MD, PhD, MPH
Atopic dermatitis (AD) significantly impacts physical, social, and psychological well-being. Recently, novel and more effective treatment options have been approved, including those targeting interleukin (IL)-13. Tune in to watch this webcast on incorporating these agents to optimize care for patients with moderate to severe AD with Terry Faleye, Dermatology Physician Assistant at DermSurgery Associates in Houston, Texas, and Dr. Jonathan Silverberg, Professor, Director of Clinical Research, and Director of Patch Testing at George Washington University School of Medicine and Health Sciences in Washington, DC.
Guest: Cara Dolin, MD
Guest: Jennifer Simpson
Guest: Diana Girnita, MD ,PhD
Explore this video roundtable featuring an interdisciplinary panel of experts discussing a woman’s journey with mycophenolate therapy and strategies to approach risk mitigation. Learn more about how to provide critical education on the risks of mycophenolate, the importance of effective contraception, and navigating family planning.
Host: Raj Chovatiya, MD, PhD
Guest: Steven R. Feldman, MD, PhD
The biologics we know are revolutionary treatments for our patients with psoriasis and now other inflammatory skin diseases. So how do biosimilars play a part in the evolving treatment of psoriasis? Learn more with Dr. Raj Chovatiya as he dives further into biosimilars with Dr. Steve Feldman, Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in Winston-Salem, North Carolina.
Host: Raj Chovatiya MD, PhD
Guest: Jennifer Soung, MD
Guest: Einjuan James Song, MD, FAAD
The atopic dermatitis treatment landscape has evolved over the past several years. To catch up on the current treatment options available and the novel therapies in development, Dr. Raj Chovatiya speaks with Drs. James Song and Jennifer Soung. Dr. Song is the Director of Clinical Research for Frontier Dermatology Partners in Everett, Washington, and Dr. Soung is the Director of Clinical Research at Southern California Dermatology in Santa Ana, California.
Host: Raj Chovatiya MD, PhD
Guest: George Han, MD, PhD
The discovery of the IL-23 pathway has revolutionized the treatment of psoriasis. Learn more about the current state of IL-23 inhibition in psoriasis management with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale, New York.
Host: Raj Chovatiya MD, PhD
Guest: Matthew Zirwas, MD
Guest: Douglas DiRuggiero, DMSc, PA-C
When managing atopic dermatitis, it’s up to the patient to determine how much therapeutic intervention they want to pursue, which underscores the importance of applying shared decision-making to practice. Joining Dr. Raj Chovatiya to share their perspectives on how we can utilize shared decision-making in atopic dermatitis care are Dr. Matthew Zirwas and Mr. Douglas DiRuggiero. Dr. Zirwas founded Bexley Dermatology Research Clinic in Columbus, Ohio where he specializes in adult eczema, and Mr. DiRuggiero is a certified physician assistant at the Skin Cancer and Cosmetic Dermatology Center in Rome, Georgia.
Host: Raj Chovatiya MD, PhD
Guest: George Han, MD, PhD
Our understanding of TYK2’s role in the pathophysiology of psoriasis has recently evolved, leading to new treatment options like deucravacitinib. Deucravacitinib is the first approved TYK2 inhibitor approved for moderate to severe plaque psoriasis. Learn more about this treatment option and the role of TYK2 with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale, New York.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jonathan Silverberg, MD, PhD, MPH
Atopic dermatitis is more than a disease of the skin. It’s a complex and heterogeneous inflammatory disease mediated by multiple T-cell–driven inflammatory pathways, like the OX40 pathway, leading to chronic and persistent symptoms and significant burden.1-4 Explore the heterogeneity of atopic dermatitis and the importance of OX40 signaling in disease pathogenesis with Dr Charles Turck and Dr. Jonathan Silverberg, Professor and Director of Clinical Research and the Director of Patch Testing at George Washington University School of Medicine and Health Sciences.
References:
- Silverberg JI. Clinical Management of Atopic Dermatitis. 1st ed. 2018.
- Ratchataswan T, et al. J Allergy Clin Immunol Pract. 2021;9:1053-1065.
- Weidinger S, et al. Nat Rev Dis Primers. 2018;4:1.
- De Bruyn Carlier T, et al. J Autoimmun. 2021;120:102634.
©2023 Amgen Inc. All rights reserved. USA-451-80031 8/23
Host: Raj Chovatiya MD, PhD
Guest: Jason E. Hawkes, MD, MS, FAAD
Generalized pustular psoriasis is a rare inflammatory skin disease that can be life-threatening if left untreated, and treatment typically involves the use of therapies approved for plaque psoriasis. However, that could all be changing thanks to the recent understanding of IL-36’s role in generalized pustular psoriasis and the development of the treatment option spesolimab. Learn more with Dr. Raj Chovatiya and Dr. Jason Hawkes, medical dermatologist in the Greater Sacramento area who also sits on the National Psoriasis Foundation Medical Board and Scientific Advisory Committee.
Host: Raj Chovatiya MD, PhD
Guest: Jason E. Hawkes, MD, MS, FAAD
Roflumilast and tapinarof are two of the new topical nonsteroidal therapies for plaque psoriasis that have several advantages over the traditional topical steroids. Learn more about how emerging topical nonsteroidals could impact your patients with plaque psoriasis with Dr. Raj Chovatiya and Dr. Jason Hawkes, a medical dermatologist in the Greater Sacramento area who also sits on the National Psoriasis Foundation Medical Board and Scientific Advisory Committee.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Gil Melmed, MD, MS
The inflammation biosimilar development process uses a stepwise approach with increasing certainty to generate the totality of evidence, which demonstrates the safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed.1,2 Dive further into the role of totality of evidence in the inflammation biosimilar development and approval process with Dr. Gil Melmed, Director of Inflammatory Bowel Disease Clinical Research at the Cedars-Sinai and Professor of Medicine at Cedars-Sinai and at the David Geffen School of Medicine at University of California, Los Angeles. Dr. Melmed was compensated for participating in this program.
References:
-
US Food and Drug Administration. Quality Considerations in Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product Guidance for Industry. Published online April 2015. Accessed March 22, 2023. https://www.fda.gov/media/135612/download
-
US Food and Drug Administration. Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Guidance for Industry. Published online April 2015. Accessed March 22, 2023. https://www.fda.gov/media/82647/download
©2023 Amgen Inc. All rights reserved. USA-CBU-81605 5/23
Host: Jennifer Caudle, DO
Guest: Jeran Wadlow
Guest: Josh Elmassian, MBA
Allergan Medical Institute® has taken a personalized approach to training HCPs in medical aesthetics with the launch of AMI Online. Discover multiple online courses spanning the Allergan Aesthetics portfolio, including content on JUVÉDERM® VOLUX® XC. Experience how AMI Online’s evidence-based and progressive training curricula can educate and empower the aesthetics community. Join Dr Jennifer Caudle as she speaks with Jeran Wadlow, Associate Director, Digital at Allergan Medical Institute® in Irvine, California, and Josh Elmassian, Director of JUVÉDERM® US Commercial Business and Marketing at Allergan Aesthetics, in Irvine, California.
© 2023 AbbVie. All rights reserved.
PRT162857 06/23
Host: Jason J. Luke, MD, FACP
Guest: Tara Mitchell, MD
The 5-year recurrence rates for stage IIB and IIC melanoma are up to 46%, but now new immunotherapy options are FDA-approved for the adjuvant treatment of stage IIB and IIC melanoma. Find out why this matters and hear Drs. Jason Luke and Tara Mitchell break down the latest data on treating stage IIB and IIC melanoma with adjuvant immunotherapy.
Host: Raj Chovatiya MD, PhD
Guest: Martina J. Porter, MD
Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurative (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.
Host: Raj Chovatiya MD, PhD
Guest: Martina J. Porter, MD
For patients with hidradenitis suppurativa (HS) the exact cause of the condition is still being researched. So what therapies are currently available to treat this painful condition? To discuss what you need to know, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.
Host: Raj Chovatiya MD, PhD
Guest: Britt Craiglow, MD
The future looks promising for alopecia areata patients as two JAK inhibitors have been tested in clinical trials while other treatment studies are ongoing. So what should clinicians know about these therapies? Learn more as Dr. Raj Chovatiya speaks to Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist with Dermatology Physicians of Connecticut.
Host: Raj Chovatiya MD, PhD
Guest: Britt Craiglow, MD
Initially approved for the treatment of rheumatoid arthritis, baricitinib is now the first FDA-approved treatment for patients with alopecia areata. So what can patients look forward to with this new therapy? Dive in with Dr. Raj Chovatiya as he’s joined by Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist at Dermatology Physicians of Connecticut.
Host: Marshall Miller
This episode of Rub Some Dirt in It is getting curiouser and curiouser. See if you can solve these two cases before host Marshall Miller reveals the rare and unexpected diagnoses.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Justin Cheeley, MD
Proper access to medication can present challenges for the doctor and patient but is necessary to achieve optimal patient outcomes. So how can they work together to eliminate this burden? To discuss this further, Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of General Internal Medicine and Dermatology and the Director of Inpatient Dermatology at Emory School of Medicine.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Justin Cheeley, MD
Patients with IBD, arthritis, or other disorders of the immune system may be at a higher risk for developing pyoderma gangrenosum (PG). So how can clinicians better manage their patients with PG? Explore this rare condition as Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of General Internal Medicine and Dermatology and the Director of Inpatient Dermatology at the Emory School of Medicine.
Host: Matthew S. Keller MD
Host: Monica Schwartzman, MD, MS
Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians help patients find the right medication? To discuss this topic together, Dr. Matthew Keller is joined by fellow ReachMD host, Dr. Monica Schwartzman, who is also a Rheumatologist.
Host: Michael Greenberg, MD
Guest: Jonathan S. Weiss, MD
Physician assistants (PAs) are licensed to practice medicine to provide many of the same services as a physician. And they may even train in dermatology. But what do we need to take into consideration when bringing a PA into a dermatology practice? Joining Dr. Michael Greenberg to discuss the ethics of this all-too-common situation is Dr. John Weiss, President and Co-Managing Partner at Georgia Dermatology Partners.
Guest: Natasha Mesinkovska, MD, PhD
Given the rising prevalence of alopecia areata, what do we need to know about patients’ unmet needs? And what are the barriers clinicians face when managing patients? Here to talk about alopecia areata is Dr. Natasha Mesinkovska, Associate Professor and Vice Chair for Clinical Research in the Dermatology School of Medicine at the University of California Irvine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Arash Mostaghimi, MD, MPA, MPH
Key assessments like the Severity of Alopecia Tool and the Alopecia Areata Investigator Global Assessment tool can help us assess the severity and impact of alopecia areata on our patients. Joining Dr. Charles Turck to discuss how we can implement these tools into practice is Dr. Arash Mostaghimi, Assistant Professor at Harvard Medical School and Director of the Dermatology Inpatient Service at Brigham and Women’s Hospital in Boston.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Natasha Mesinkovska, MD, PhD
Alopecia areata is an autoimmune condition with a complex pathophysiology. That’s why Dr. Charles Turck speaks with Dr. Natasha Mesinkovska from the University of California, Irvine about the pathophysiology of alopecia areata and how its underlying mechanisms impact what we see in practice.
Host: William Mencia, MD, FACEHP, CHCP
Guest: Julie Blatt, MD
Guest: Taizo Nakano, MD
PIK3CA-related overgrowth spectrum (PROS) refers to various clinical entities that share the same pathogenetic mechanism. These disorders are caused by somatic gain-of-function PIK3CA mutations. Diagnosis of PROS is often challenging and requires DNA sequencing of the affected tissue. PIK3CA genetic mutations vary greatly depending on the tissue being tested. PROS is not considered an inherited disease.
The road to a diagnosis of a rare disease can be a long, winding process. Because of its rarity, a wide spectrum of symptoms, and disease heterogeneity, patients may feel alone and as though they are the only ones with the disease. Management of PROS currently involves symptomatic treatment of its manifestations; an unmet need exists for targeted, systemic therapies.
Currently, there is no cure for PROS. This educational activity will assist the interprofessional care team to better understand, apply, and interpret advances in current and emerging evidence that will help bridge the gap toward faster adoption into patient care.
Host: William Mencia, MD, FACEHP, CHCP
Guest: Julie Blatt, MD
Guest: Taizo Nakano, MD
PIK3CA-related overgrowth spectrum (PROS) refers to various clinical entities that share the same pathogenetic mechanism. These disorders are caused by somatic gain-of-function PIK3CA mutations. Diagnosis of PROS is often challenging and requires DNA sequencing of the affected tissue. PIK3CA genetic mutations vary greatly depending on the tissue being tested. PROS is not considered an inherited disease.
The road to a diagnosis of a rare disease can be a long, winding process. Because of its rarity, a wide spectrum of symptoms, and disease heterogeneity, patients may feel alone and as though they are the only ones with the disease. Management of PROS currently involves symptomatic treatment of its manifestations; an unmet need exists for targeted, systemic therapies.
Currently, there is no cure for PROS. This educational activity will assist the interprofessional care team to better understand, apply, and interpret advances in current and emerging evidence that will help bridge the gap toward faster adoption into patient care.
Host: Jason D. Bloom, MD, FACS
Guest: Carolyn I. Jacob, MD, FAAD
The injection of botulinum toxin type A products can diminish unwanted facial wrinkles and improve appearance. Do you fully understand how to use these products? Tune in as Dr. Jason Bloom and Dr. Carolyn Jacob take us through the pharmacologic similarities, differences, and duration of effect for the 4 FDA-approved neuromodulators and demonstrate specific injection techniques for the masseter, platysma bands, “bunny lines,” and the glabellar complex.
Host: Jason D. Bloom, MD, FACS
Guest: Carolyn I. Jacob, MD, FAAD
The injection of botulinum toxin type A products can diminish unwanted facial wrinkles and improve appearance. Do you fully understand how to use these products? Tune in as Dr. Jason Bloom and Dr. Carolyn Jacob take us through the pharmacologic similarities, differences, and duration of effect for the 4 FDA-approved neuromodulators and demonstrate specific injection techniques for the masseter, platysma bands, “bunny lines,” and the glabellar complex.
Host: Matthew S. Keller MD
Guest: Natasha Mesinkovska, MD, PhD
Alopecia areata affects more than 300,000 people in the United States each year, causing hair loss to the scalp, eyebrows, and eyelashes. But recent studies have shown that the Janus kinase inhibitor drug baricitinib can help significantly regrow hair for patients. To find out more about what this first-ever FDA approval of a systemic treatment could mean for patients with alopecia areata, Dr. Matthew Keller speaks with Dr. Natasha Mesinkovska, Associate Professor of Dermatology and Vice Chair for Clinical Research of Dermatology at University of California Irvine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Nick Kusnezov, MD
Can you balance locum tenens with a full-time career? To answer that question, Dr. Charles Turck is joined by board-certified orthopedic surgeon, Dr. Nicholas Kusnezov, to walk us through his journey from joining the military to locum tenens.
Host: Jennifer Caudle, DO
Guest: Roni Devlin, MD
As rates of burnout continue to rise in the healthcare community, how can help our female physicians combat it? Dr. Jennifer Caudle joins Infectious Disease Specialist, Dr. Roni Devlin, to discuss how we can prevent burnout for female physicians.
Host: Michael Greenberg, MD
Guest: Lynn McKinley-Grant, MD, FAAD
Psoriatic disease looks and feels different for people of color, and these differences may affect their diagnosis, treatment, and—by extension—quality of life. In fact, more than 50 percent of people with psoriatic arthritis experience a 2-year delay in diagnosis and a lower quality of life compared to white patients. So how can we help close the diagnostic gap and provide better care for our patients of color with psoriatic arthritis? To find out, Dr. Michael Greenberg is joined by Dr. Lynn McKinley-Grant, Associate Professor of Dermatology at Howard University College of Medicine.
Host: John J. Russell, MD
Guest: Randy Young, MD
As Monkeypox continues to spread across non-endemic countries more and more, how can we detect it in our patients? And what’s being done to stop the spread? Guest and fellow ReachMD Host Dr. Randy Young, a Pulmonary Disease and Critical Care Medicine physician, joins Dr. John Russell to discuss what physicians should be looking out for, and how this virus has impacted public health.
Host: Michael Greenberg, MD
Guest: Esther Freeman, MD, PhD
Guest: Steven Chen, MD, MPH, MHPEd
With the recent rise of monkeypox cases around the world, dermatologists will be some of the first to evaluate and diagnose patients with the disease. So to help those on the frontlines, Dr. Esther Freeman, Director of Global Health Dermatology at Massachusetts General Hospital and Dr. Steven Chen, Assistant Professor of Dermatology at Harvard Medical School, share what dermatologists need to know about monkeypox.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Jennifer Caudle, DO
Guest: Maurice G. Sholas, MD, PhD
After years of serving the New Orleans community, one physician decided to pursue locum tenens work. Dr. Jennifer Caudle joins Dr. Maurice Sholas, a pediatric physical rehabilitation physician, to share his experiences with locum tenens and in New Orleans.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Samantha Conroy, MD
Locum tenens can improve quality of care around the globe—especially in remote and underserved communities. To share how, Dr. Paul Doghramji joins Dr. Samantha Conroy, a family practice obstetrician to share her experiences working as a locum tenens obstetrician in underserved communities.
Host: Jennifer Caudle, DO
Guest: April W. Armstrong, MD, MPH
Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM
There's good news for patients and clinicians dealing with the challenges of psoriasis or psoriatic arthritis (PsA). Novel and emerging therapies exist that can help improve symptoms, and slow or prevent disease progression. In this fast-paced, clinical discussion, you'll hear from two leading experts who will share recent evidence and highlights from the American Academy of Dermatology (AAD) Annual Meeting that support using novel biologic and targeted synthetic agents for psoriasis and PsA. As part of the discussion, they also examine a patient case illustrating how you can optimize treatment plans, integrate the latest guideline recommendations in your practice, and encourage shared decision making with your patients.
Host: Jennifer Caudle, DO
Guest: April W. Armstrong, MD, MPH
Guest: Allan Gibofsky, MD, JD, MACR, FACP, FCLM
There's good news for patients and clinicians dealing with the challenges of psoriasis or psoriatic arthritis (PsA). Novel and emerging therapies exist that can help improve symptoms, and slow or prevent disease progression. In this fast-paced, clinical discussion, you'll hear from two leading experts who will share recent evidence and highlights from the American Academy of Dermatology (AAD) Annual Meeting that support using novel biologic and targeted synthetic agents for psoriasis and PsA. As part of the discussion, they also examine a patient case illustrating how you can optimize treatment plans, integrate the latest guideline recommendations in your practice, and encourage shared decision making with your patients.
Host: Michael Greenberg, MD
Guest: Brook Brouha, MD, PhD
How might genomics help us provide better care for our patients? Joining Dr. Michael Greenberg to share how he’s utilizing genomics in practice is Dr. Brook Brouha, a dermatologist and dermatopathologist at West Dermatology in San Diego, California.
Host: Matthew S. Keller MD
Guest: Michael Greenberg, MD
Are you looking to increase business at your dermatology practice? One simple solution is practicing goodness—in other words, being good and kind to your patients and their families. Joining Dr. Matthew Keller to explain why goodness is the best practice builder is fellow ReachMD Host Dr. Michael Greenberg.
Host: Michael Greenberg, MD
Guest: Dustin Portela, DO
The prevalence of social media has grown significantly over the past few decades, and within the field of medicine, we’ve seen a rise in dermatologists using these platforms to grow their professional network, improve patient care, and provide essential education. But what ethical challenges arise from a widespread social media presence, and how can we navigate those challenges? To find out, Dr. Michael Greenberg speaks with Dr. Dustin Portela about his online presence as 208SkinDoc.
Host: Linda Stein Gold, MD
Guest: Hilary Baldwin, MD
Microencapsulation technology is allowing us to combine agents that were previously incompatible. One new formulation is preserving the advantages of BPO while minimizing limitations and improving adherence for patients with acne. Join Dr. Linda Stein Gold and Dr. Hilary Baldwin as they walk through a case scenario to demonstrate how the new formulation of BPO and tretinoin fits into clinical practice.
Host: Linda Stein Gold, MD
Guest: Neal Bhatia, MD
Guest: Julie C. Harper, MD
Do you ever wish you could mix the unmixable when it comes to treatment selection? Microencapsulation is the answer! This new technology preserves the advantages of BPO while minimizing limitations for patients with acne and rosacea. Tune in to our chapterized panel discussion with Drs. Linda Stein Gold, Julie Harper, and Neal Bhatia and view 3D animation revealing how microencapsulation works.
Host: Neal Bhatia, MD
Guest: Jeffrey Sugarman, MD, PhD
Drs. Neal Bhatia and Jeff Sugarman discuss how the new formulation of benzoyl peroxide can change our treatment armamentarium for rosacea. Find out how microencapsulation technology stabilizes BPO and improves outcomes for patients.
Host: Jane Mast, PA-C, MPAS, DMSc
Guest: Douglas DiRuggiero, DMSc, PA-C
Join podcast guest Doug DiRuggiero, PA, a certified physician assistant and the founding president of Georgia Dermatology Physician Assistant Society, and host Jane Mast, a Novartis Medical Director and certified physician assistant in a discussion focusing on the diagnosis and management of psoriasis in pediatric and adolescent patients.
During their discussion, they address the following topics:
- Important clinical features of psoriasis in children and adolescents and how they may differ from those in adult patients
- Communication strategies to use when talking to parents about their child’s psoriasis
- Psychosocial impact of psoriasis
- Approaches to management
This podcast is sponsored by Novartis Pharmaceuticals Corporation and the podcast guest is being compensated for his time.
© 2021 Novartis Pharmaceuticals Corporation
Host: Michael Greenberg, MD
Guest: Arash Mostaghimi, MD, MPA, MPH
Acne vulgaris is a common dermatologic condition with a variety of treatment options available. But due to its multifactorial pathogenesis and the limitations of current therapies, evolving treatments and management guidelines are needed. Fortunately, several therapies have emerged in recent years, so to learn more about what’s new in the treatment landscape, Dr. Michael Greenberg speaks with Dr. Arash Mostaghimi, Director of Dermatology Inpatient Service at Brigham and Women’s Hospital.
Host: John J. Russell, MD
Guest: Joseph E. Bavaria, MD
Featuring a wide range of disciplines and a new approach to comprehensive care, what do we need to know about the Aorta Center at Penn Medicine? Dr. John Russell is joined by Dr. Joseph E. Bavaria to dive into this aortic program and discuss a new approach to comprehensive care.
Host: William Mencia, MD, FACEHP, CHCP
Guest: Andrew F. Alexis, MD, MPH
There is often a delay in the diagnosis of psoriasis and/or psoriatic arthritis for people with skin of color. Among the multiple factors that cause this disparity are a low index of suspicion for such a diagnosis in skin of color and a lack of familiarity with the morphology of these conditions in richly pigmented skin. Join Drs. William Mencia and Andrew Alexis as they address pathways to overcoming these systemic and experiential healthcare barriers.
Host: Sergio Schwartzman, MD
Guest: April W. Armstrong, MD, MPH
Guest: Philip J. Mease, MD, MACR
Integrating routine assessments of psoriatic arthritis (PsA)-related structural progression has proven challenging in clinical practice. Join Drs. Sergio Schwartzman, Philip Mease, and April Armstrong as they discuss evidence that frequent monitoring of PsA structural progression permits earlier intervention with effective therapies as well as provides indications for when to switch to another class of agent. They also address which therapeutic agents have been shown to impact PsA structural progression in clinical trials and provide insight into how best to incorporate collaborative treatment strategies across disciplines. These practices are likely to improve outcomes for patients with PsA, so be sure to stay informed.
Host: Matthew S. Keller MD
Guest: Linda Stein Gold, MD
For many years, acne scarring was considered to be a result of severe acne, but recent research shows that scarring can affect any patient regardless of the severity. Additionally, acne scarring can significantly reduce a patient's quality of life, which is why it's important that treatment is started early to achieve better outcomes. So to help us gain a better understanding of the assessment and treatment strategies currently available, Dr. Matthew Keller speaks with Dr. Linda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System in Detroit.
Host: Linda Stein Gold, MD
Guest: Keri Holyoak, PA-C, MPH
When it comes to psoriasis, it’s important to not just treat the skin, but also the patient as a whole. That’s why Dr. Linda Stein Gold and Keri Holyoak are here to discuss the often-overlooked psychosocial burden of psoriasis and how we can talk to our patients about their mental health.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sandy Marks
Guest: Kim Horvath, JD
Guest: Kyle Thomson, JD
With telehealth services expanding during the COVID-19 pandemic, has our access to them changed? To better understand this, Dr. Charles Turck meets with Sandy Marks, Kim Horvath, and Kyle Thomson from the AMA to explore what’s been done to provide Medicare coverage during a public health emergency and what’s on the horizon for telehealth access.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
Host: Jennifer Caudle, DO
Guest: Sarah Ali, MD
From working in a big city to taking on an assignment in a small mountain village, Dr. Sarah Ali from the Ventura County Medical Center joins Dr. Jennifer Caudle to talk about her adventures abroad with locum tenens and share key lessons she learned along the way.
Guest: Vivian Shi, MD, FAAD
Atopic dermatitis affects patients’ lives in a way that goes beyond just visible symptoms. In fact, many patients with atopic dermatitis also suffer from anxiety, depression, and attention deficit hyperactivity disorder. That’s why Dr. Vivian Shi is here to review available tools that can help us assess the severity of the visible and invisible impacts of atopic dermatitis.
VERSION 2.0 | DECEMBER 2021 | ABBV-US-00687-MC
Host: Jennifer Caudle, DO
Guest: Melodie Young, MSN
Plaque psoriasis is canonically characterized by red, scaly, well demarcated plaques; however, the impact of this chronic systemic disease cannot be fully understood by the extent of skin involvement alone. Moderate psoriasis can have a large impact on patients due to factors such as involvement of special areas (such as the scalp) and persistent itching. Reaching a better understanding of these patients requires looking beyond skin involvement, assessing all aspects of disease, and considering patient perspectives.
Ms. Melodie Young, a Nurse Practitioner specialist of dermatology, joins Dr. Jennifer Caudle to give us deeper insight into this systemic disease, the potential impact on patients with moderate disease, and important aspects of psoriasis to consider in disease assessment.
USA-407-81472
Host: Paul P. Doghramji, MD, FAAFP
Guest: Mojgan Saber, MD
Can Locum Tenens be an option for healthcare professionals just completing their residency? Dr. Paul Doghramji is joined by Dr. Mojgan Saber to share her own experience as well as tips and tricks for residents looking at Locum Tenens right after residency.
Host: Michael Greenberg, MD
Guest: Howard K. Steinman, MD
We always want patients to leave our office feeling happy, healthy, and pleased with their care, but unfortunately, that isn't always the case. The good news, however, is that the acronym BLAST can help guide our conversations with patients who are less than satisfied with their care. Joining Dr. Michael Greenberg to break down this five-step method for speaking with displeased patients is Dr. Howard Steinman, a board-certified dermatologist and fellow of the American College of Mohs Surgery.
Host: Charles P. Vega, MD
Guest: Sateria Venable
Regional healthcare disparities are biases that are based on where people live. Are your patients’ treatment options being impacted and limited by their geographical location? Join us as our two experts discuss how to support broader policy issues and highlight the importance of diagnostic algorithms that have been developed with diverse input. These steps may be of value in your clinical practice to ensure all patients have equal access to care regardless of their epidemiologic, socioeconomic, or insurance circumstances.
Host: Jennifer Caudle, DO
Guest: Stephen Hanauer, MD
Even though biosimilars serve as a much-needed treatment option for patients in several fields of medicine, gastroenterologists have been reluctant to adopt them. Joining Dr. Jennifer Caudle to explore why this might be and the evolving role of biosimilars in anti-inflammatory care for GI patients is Dr. Stephen Hanauer, Professor of Medicine at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.
USA-CBU-81030
Host: Michael Greenberg, MD
Guest: Robert T. Brodell, MD
As children, stories and fables capture our imaginations and even teach us some important life lessons, and our love of stories isn't necessarily something we grow out of. After all, as adults, we're constantly hearing news stories and catching the latest movies, podcasts, and shows. So might there be a role for storytelling in our visits with patients? To find out, Dr. Michael Greenberg speaks with Dr. Robert Brodell, Professor and Chair in the Department of Dermatology and Professor of Pathology at the University of Mississippi Medical Center.
Host: Matthew S. Keller MD
Guest: Omer Ibrahim, MD
In this episode, you’ll hear from board-certified dermatologist Dr. Omer Ibrahim about the rising prevalence of bed bug infestations, diagnostic and treatment strategies, and how we can help patients manage and prevent bed bug infestations.
Host: Michael Greenberg, MD
Guest: Joel Schlessinger, MD
Spa dermatology has morphed over the last 20 to 30 years, but not all of those changes benefited our patients. In fact, there are now several ethical and practical concerns when it comes to illegitimate med spas. Joining Dr. Matthew Keller to share those considerations and what we as dermatologists need to know so we can help guide our patients is board-certified dermatologist and cosmetic surgeon Dr. Joel Schlessinger.
Host: Michael Greenberg, MD
Guest: Sam Polesie, PhD
Can technology play a role in assessing melanoma? Dr. Michael Greenberg discusses the use of artificial intelligence in dermatology with Dr. Sam Polesie, a specialist physician in the Department of Dermatology and Venereology at the Sahlgrenska University Hospital in Gothenburg, Sweden.
Host: Michael Greenberg, MD
Host: Matthew S. Keller MD
Curious about the use of topical therapy to treat a variety of dermatological conditions like eczema and molluscum contagiosum? Here to share their experiences with topical therapy in clinical practice are ReachMD hosts Dr. Michael Greenberg and Dr. Matthew Keller.
Host: Matthew S. Keller MD
Guest: Maria L. Wei MD, PhD
Wildfires are most often associated with respiratory and cardiovascular health threats, but could they also affect the skin? That’s the exact question dermatologist and melanoma specialist Dr. Maria Wei sought to answer with her recent study and the one that she addresses with Dr. Matthew Keller.
Host: Matt Birnholz, MD
Guest: April W. Armstrong, MD, MPH
Guest: Laura Ferris, MD, PhD
When dermatologists and psoriasis patients fail to align on treatment expectations, this can lead to missed opportunities in achieving higher levels of skin clearance. Fortunately, utilizing certain therapeutic and counseling strategies can help dermatologists better align with their patients and improve their standards of care. Joining Dr. Matt Birnholz to share these practical strategies are Drs. April Armstrong and Laura Ferris.
VERSION 1.0 | MAY 2021 | ABBV-US-00466-MC
Host: Michael Greenberg, MD
In honor of Skin Cancer Awareness Month, Dr. Michael Greenberg reflects on a close call one of his patients had with skin cancer and how that experience taught him the importance of trusting his patients’ intuitions and easing their fears.
Guest: April Armstrong, MD, MPH
Since we’re starting to reevaluate how we think about psoriasis severity and which patients are eligible for systemic therapies, Dr. April Armstrong leading dermatologist from University of Southern California is here to walk us through how traditional classifications of disease severity may not be sufficient to reflect the full impact of psoriasis on patients.
VERSION 1.0 | APRIL 2021 | ABBV-US-00440-MC
Host: Matt Birnholz, MD
Guest: Alexis Ogdie, MD, MSCE
Axial psoriatic arthritis (axPsA) is a challenging clinical entity to characterize, with a prevalence ranging anywhere between 12.5% and 78% of psoriatic arthritis patients because of varied definitions and inclusion criteria. To learn more about how we can better define and diagnose axPsA, Dr. Matt Birnholz is joined by Dr. Alexis Ogdie, Associate Professor of Medicine and Epidemiology at the University of Pennsylvania.
4/21 M-XAT-1400586
Host: Michael Greenberg, MD
Guest: Peter B. Crino, MD, PhD
How does tuberous sclerosis impact patients? Dr. Michael Greenberg joins Dr. Peter Crino, the chair of the Department of Neurology at the University of Maryland School of Medicine, to discuss tuberous sclerosis complex, or TSC.
Host: Joel L. Cohen, MD
The differences between biostimulators and dermal fillers are simple yet critically important to their safe and successful use. With the help of 2D animation, Dr. Joel Cohen presents different techniques to optimize results in patients and minimize the risk of adverse effects.
Host: Joel L. Cohen, MD
Guest: Jason D. Bloom, MD
Dr. Joel Cohen and Dr. Jason Bloom discuss the importance of neuromodulator selection and accurate dosing for the glabella and upper face. Dr. Bloom takes us through a patient demonstration of optimal injection techniques and dosing while addressing strategies to minimize the risk for adverse events.
Host: Joel L. Cohen, MD
Guest: Carolyn I. Jacob, MD, FAAD
What does the future hold for aesthetics? The 4 four available neuromodulators share a similar mechanism of action and efficacy profiles, but they each have their own unique characteristics, and now an emerging agent is about to enter the scene. Dr. Joel Cohen and Dr. Carolyn Jacob discuss the subtle differences among neuromodulators and the importance of dosing for duration, specifically for the glabella and upper face. They also explore potential adverse events and strategies to minimize your patients’ risks.
Host: Andrew Alexis, MD, MPH
Guest: Linda Stein Gold, MD
Depression, anxiety, failure to thrive, unemployment, low self-esteem, and suicidal ideation. What could possibly be contributing to all of these consequences? The culprit is acne—didn’t expect that, did you? Hear from dermatologists Dr. Andrew Alexis and Dr. Linda Stein Gold as they discuss the proper assessment of acne, its location—particularly beyond the face—and the differences to keep in mind when assessing skin of color. Faculty also examine the role that selective retinoid therapies play in treating acne and preventing the development of both the physical and psychological scars associated with this condition.
Host: Michael Greenberg, MD
To help alleviate pressure from hospitals that are experiencing a high influx of patients due to the COVID-19 pandemic, dermatologist Dr. Michael Greenberg decided to keep his doors open and is now sharing what it’s like to see patients during this outbreak.
Published April 3, 2020
Guest: Peter A. Lio, MD
Guest: Mark Boguniewicz, MD
Guest: Eric Simpson, MD, MCR
Please note: This activity is no longer available for continuing education credit.
Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel discusses how they would approach the baby's treatment, emerging options for this vulnerable patient population, and if anything can be done now to prevent progression of the atopic march later.
Guest: Peter A. Lio, MD
Guest: Mark Boguniewicz, MD
Guest: Eric Simpson, MD, MCR
Please note: This activity is no longer available for continuing education credit.
Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.
Guest: Peter A. Lio, MD
Guest: Mark Boguniewicz, MD
Guest: Eric Simpson, MD, MCR
Please note: This activity is no longer available for continuing education credit.
A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular history and dupilumab's conjunctivitis risk. Find out what the experts have to say about this doctor's dilemma.
Host: Peter A. Lio, MD
Guest: Eric Simpson, MD, MCR
Guest: Mark Boguniewicz, MD
Please note: This activity is no longer available for continuing education credit.
“I begged my doctor for something else – there had to be something else,” Pam.
For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of the several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.
Host: Chrysalyne D. Schmults, MD, MSCE (Chair)
Guest: Omid Hamid, MD
Guest: Anokhi Jambusaria, MD, MSCE, FAAD
Please note: This activity is no longer available for continuing education credit.
Available treatment options for cutaneous squamous cell carcinoma (cSCC) are expanding and involving more interdisciplinary dialogue. This slides/audio presentation features 3 clinical case scenarios with feedback and commentary by a medical oncologist, surgeon, and dermatologist exploring topics in immunotherapy, Mohs surgery, and complex patient presentations.
Host: Chrysalyne D. Schmults, MD, MSCE (Chair)
Guest: Omid Hamid, MD
Guest: Anokhi Jambusaria, MD, MSCE, FAAD
Please note: This activity is no longer available for continuing education credit.
The recent approval of the first immunotherapeutic agent for cutaneous squamous cell carcinoma (cSCC) is changing the way healthcare providers treat patients with inoperable cSCC. In this roundtable discussion, a cSCC survivor draws upon his experience with the cancer when surgery and chemotherapy failed him, as our multidisciplinary faculty panel focus on how to optimally select patients with cSCC for treatment with immunotherapy.
Host: Matt Birnholz, MD
Guest: Mark G. Lebwohl, MD
Tune in as Dr. Mark Lebwohl, professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine, shares a challenging case of a patient with both psoriasis and Crohn's disease.
Host: Michael Greenberg, MD
Guest: Madelaine A. Feldman, MD, FACR
A multidisciplinary approach between dermatologists and rheumatologists is required for treating and caring for patients with psoriatic arthritis (PsA). So how should these two specialists work together to achieve the best outcome for their patients? What challenges do they each face, and how can they overcome them?
Dr. Michael Greenberg, dermatologist from the Illinois Dermatology Institute, and Dr. Madelaine Feldman, Clinical Associate Professor of Medicine at Tulane University School of Medicine and practicing rheumatologist, come together to provide their perspectives from their careers on this topic.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Guest: Alexis Ogdie, MD, MSCE
Along with the management of psoriatic arthritis, many patients also struggle with multiple, underlying comorbidities, increasing the complexity of the disease. In a review of the associated comorbidities that can emerge from PsA, Dr. Alexis Ogdie brings another aspect to the forefront: the all-too-often underrecognized comorbidities and risk factors.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Host: Jennifer Caudle, DO
For the two percent of Americans diagnosed with psoriasis, proper and individualized treatment is essential in improving a patient’s quality of life, as Dr. Jennifer Caudle explains.
Guest: Adrienne Rencic, MD, PhD
Many psoriatic arthritis patients struggle in determining the proper physician they should seek for treatment and care management. Since dermatologists are usually consulted first due to skin manifestations, it’s crucial that they are able to recognize the symptoms of PsA and know when to refer the patient to another specialist. Dr. Adrienne Rencic, a dermatologist in Glen Mills, PA, emphasizes the power of communication to achieve good coordination of care.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Guest: Robin K. Dore, MD
Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Guest: Elizabeth Volkmann, MD, MS
When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Guest: J. Eugene Huffstutter, MD
Care coordination is key in ensuring that your psoriatic arthritis (PsA) patients maintain control of their disease, but it’s not always easy. To help you overcome this common challenge, Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, shares his perspective on how you can coordinate your PsA patients’ care with not only their healthcare team but also their family members.
Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Released May 22, 2017
Dr. Becky Fitzgerald, a dermatologist in private practice in Los Angeles, CA and on the clinical faculty at UCLA, and Dr. Sabrina Fabi, dermatologist, assistant clinical professor at the University of California, San Diego, and associate at Cosmetic Laser Dermatology, discuss Poly-L-lactid Acid (PLLA) injections and how to best employ this unique product cosmetically for patients.
Host: Brian P. McDonough, MD, FAAFP
Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has led efforts to teach clinicians about Type IV allergies as potential causes for common gastrointestinal diseases such as IBS, coining the term "allergic contact enteritis." He joins Dr. Brian McDonough to discuss intersections between dermatology and gastroenterology in the study of hypersensitivity reactions.
[Read the Article]
In a new study, researchers from the University of California-Los Angeles studied tumor response and overall survival following the administration of a new treatment among patients with advanced melanoma. This agent, called pembrolizumab, is an antibody that blocks PD-1, a protein which prevents the body's immune system from attacking the cancer.
The researchers tested pembrolizumab on more than 650 patients in North America, Europe and Australia. They looked at tumor response before and after treatment and found that the lesions were smaller in about one third of patients. In patients who responded to the treatment, seventy-five percent maintained the response at one or two years.
[Watch more videos of The JAMA Report]
Host: Jennifer Caudle, DO
When do you refer to dermatologists? And what are some of the common & uncommon dermatologic conditions that PCPs should refer to dermatologists? Host Dr. Jennifer Caudle welcomes Dr. Jeanine B. Downie to discuss some of the "hot topics" in dermatology and best practices in developing a good relationship between the primary care clinician and the dermatologist. Dr. Downie, director of Image Dermatology in New Jersey, is a fellow of the American Academy of Dermatology.
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. John Ely, Professor of Family Medicine at the University of Iowa Carver College of Medicine. Dr. Ely has written numerous articles addressing the top questions surfacing in general practice. He joins Primary Care Today to focus on perhaps the most common question asked between colleagues in family medicine: "What is this rash?"
Host: Brian P. McDonough, MD, FAAFP
Dr. Brian McDonough welcomes Dr. Jonathan Firnhaber, Clinical Assistant Professor of Family Medicine at East Carolina University School of Medicine, to provide top recommendations for prevention, assessment, and treatment of skin cancer at the primary care level.
Host: Brian P. McDonough, MD, FAAFP
From patient consultation services to remote physician visits, telemedicine is rapidly gaining a foothold in clincial practice. But what are the potential gains vs pitfalls for integrating these technologies at the primary care level? Dr. Mark Seraly, practicing dermatologist and founder of DermatologistOnCall.com, joins Dr. Brian McDonough to discuss clinical, operational, and financial trends in telemedicine today.
Host: Brian P. McDonough, MD, FAAFP
Irritable Bowel Syndrome affects an estimated one out of ten people in the US, yet the causes for this disease are multivariate and often unknown from case to case, creating a reputation in practice as a "waste basket diagnosis." Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has been a pioneer in helping clinicians better understand one potential cause of IBS. His own experience as IBS patient led to the remarkable discovery of an allergic contact enteritits underscoring his disease, which has led to new diagnostic and treatment algorithms for IBS patients nationwide. Dr. Stierstorfer joins Dr. Brian McDonough to discuss this unexpected path toward discovery and subsequent career specialization.
Host: Prathima Setty, MD
Dr. Prathima Setty welcomes board certified dermatologist Dr. Dina Nicole Anderson to discuss the various cosmetic concerns of post menopausal patients, the effects of estrogent on the skin, how to counsel patients, treatment recommendations, and much more. Dr. Anderson is a board certified dermatologist in private practice in New York City. She was also the Director of Cosmetic Dermatology at SUNY Downstate in Brooklyn, NY. Dr. Anderson is a member of various academic medical societies including American Academy of Dermatology, the Women's Dermatologic Society, and the American Society of Cosmetic Dermatology & Aesthetic Surgery.
About NAMS
The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit
The Gender, Sexuality and HIV Prevention Center at Ann & Robert H Lurie Children's Hospital of Chicago is the first of its kind facilty for adolescent patients. Host Dr. Jennifer Caudle welcoms the center's director, Dr. Robert Garofalo. Dr. Garofalo will share the center's mission of supporting multidisciplinary academic subjects including sexual health, gender, sexuality, HIV prevention and health disparities which affect adolescent and young adult populations at risk of acquiring HIV. The Center partners with similar organizations throughout the country in creating an environment where clinicians, academics and scientists can collaborate to design projects with public health significance.
Robert Garofalo, MD, MPH, is Professor of Pediatrics and Preventive Medicine at Northwestern University Feinberg School of Medicine. He is also an Attending Physician at Lurie Children's, where he directs the Adolescent/Young Adult HIV Program. Dr. Garofalo is a national authority on LGBT health issues, adolescent sexuality, and HIV clinical care and prevention.
Host: Tim Rush
As physicians' incomes diminish with reduced insurance reimbursement, physicians are faced with the problem of how to continue to offer high quality care without going broke. Some have turned to physician extenders and others have increased their patient loads to cover the increasing cost of running an office. There are lots of ways to "make money" and lots of reasons but staying within the ethics of practice is a bit tricky. Host Tim Rush welcomes Dr. Michael Greenberg, practicing dermatologist at the Illinois Dermatology Institute in Chicago, IL. Dr. Greenberg will discuss how his practice incorporates a "win-win-win" strategy that helps his practice, his patients and local charities.
Download and listen today!
Host: Steven Davis, DO
Hair loss, though a common problem, is often underappreciated for its medical and psychological impacts on patients. Host Dr. Steven Davis is joined by Dr. Paul Rose, dermatologist and past president of both the International Society of Hair Restoration and the International Society of Laser and Cosmetic Surgery, to discuss updates in medical treatment for male and female-pattern hair loss.
Guest: Christi Chang, RN
Host: Steven Davis, DO
Tanning beds are extremely popular in the United States despite the medical community's steadfast position against their use. How can we counsel our patients toward safer alternatives, and what are the risks associated with other tanning methods such as airbrushing? Speaking on this subject is Christi Chang, President and CEO of Ventura Tan, a sunless tanning company based in New Jersey. Dr. Steven Davis hosts.
Guest: Aaron Kowalski, PhD
Host: Timothy Bailey, MD
The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial pancreas project? Join guest host Dr. Timothy Bailey and his guest, Assistant Vice President and Director of Glucose Control Research at the Juvenile Diabetes Research Foundation, Dr. Aaron Kowalski as they discuss developments from controlled inpatient settings to real-world conditions and the need for regulation.
Host: Matt Birnholz, MD
The 69th annual meeting of the American Academy of Dermatology took place February 4th through the 8th, in New Orleans. Attracting approximately 16,000 participants from around the world. The conference highlighted recent advances in the diagnosis and management of dermatologic conditions, with presentations and abstracts focusing on acne, rosacea, basal cell carcinoma, squamous cell carcinoma, melanoma, among other skin conditions.
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
As the specialty of cosmetic medicine is rapidly evolving and expanding, so too are the roles of physician assistants and nurse practitioners in the field. Host Lisa Dandrea Lenell talks with some of the leading experts in plastic surgery and dermatology at the Aesthetic Extender Symposium, held October 8 - 10 in Miami Beach, Florida, which educates NPs and PAs about novel technologies and techniques in cosmetic medicine. Tune in to hear about the latest in botulinum toxins, fractionated lasers, hyaluronic fillers, the use of topical anesthetics, new methods of fat reduction and more.
Featured guests include:
- Steven Dayan, MD - board-certified facial plastic surgeon and clinical assistant professor at the University of Illinois and DePaul University in Illinois
- David Goldberg, MD - founding director of the Aesthetic Extender Symposium; clinical professor of dermatology and director of laser research at Mount Sinai School of Medicine in New York; medical director of Skin, Laser and Surgery specialists of New York and New Jersey; and co-director of Sanctuary Medical Center in Boca Raton, Florida
- Krystie Lennox, PA-C - founding director of the Aesthetic Extender Symposium who practices at Sanctuary Medical Aesthetic Center in Boca Raton, Florida
- Jason Pozner, MD - co-founder of …
Host: Mark Chyna, MD
This Conference Coverage spotlights the American Academy of Dermatology's 68th Annual Meeting, March 5 - 9 in Miami Beach, Florida. The 2010 meeting attracted a record number of attendees, and featured 370 sessions, more than 1,300 faculty, and 600 electronic posters, covering biologic drugs, light-based technologies and nanotechnologies, to name a few of the research areas.
Guest: Janet Trowbridge
Host: Steven Edelman, MD
There are a number of skin conditions that affect people with diabetes: xerosis, acanthosis nigrican, necrobiosis lipoidica diabeticorum and more. What do healthcare providers need to know to diagnose and treat their patients? Join host Dr. Steven Edelman and his guest, dermatologist specializing in diabetes, Dr. Janet Trowbridge, as they discuss skin conditions in patients with diabetes.
Guest: Krystie Lennox, PA-C
Host: Lisa Dandrea Lenell, PA-C, MPAS, MBA
More than 10 million surgical and non surgical cosmetic procedures were performed in the United States in 2008. Many of those procedures were performed by physician assistants. Krystie Lennox, the co-founder of the Aesthetic Extender Symposium, talks with host Lisa Dandrea Lenell about the state-by-state rules related to PAs performing cosmetic procedures, how to become part of this expanding specialty, and how to stay informed in this fast changing area of medicine.
Guest: David Thomas, MD, CMD
Host: Eric Tangalos, MD
How common are pressure ulcers in hospitals, nursing homes and other long-term care facilities? What clinical situations put patients at risk for developing pressure ulcers, and how are these wounds diagnosed? Dr. David Thomas, professor of internal medicine and geriatric medicine at Saint Louis University Health Sciences Center, joins host Dr. Eric Tangalos to review strategies for managing pressure ulcers.
Guest: Joel Gelfand, MD
Host: Lee Freedman, MD
Are patients with psoriasis more likely to develop cardiovascular disease, and what mechanisms might link these two conditions? Do the severity of psoriasis and the agents used to treat this condition factor in to determining a patient's cardiovascular risk? Host Dr. Lee Freedman asks Dr. Joel Gelfand, assistant professor of dermatology and medical director of the clinical studies unit in the department of dermatology at Penn Medicine, to describe what physicians should be aware of with patients who have psoriasis. Should these patients be screened more regularly for cardiovascular disease?
Produced in Cooperation with
Host: Todd Mahr, MD
Guest: Gailen D. Marshall, MD, PhD
The media often report about the effect of stress on the immune system. What research supports the idea that certain individuals are more susceptible to stress than others, and how can physicians recognize patients who might be experiencing an immunological response to stress? What mechanisms might link rhinitis, asthma and chronic urticaria to stress? Dr. Gailen Marshall, professor of medicine and pediatrics at the University of Mississippi Medical Center, discusses the fascinating relationship between a patient's mental state and immunity. Dr. Todd Mahr hosts.
Tune in for important findings presented at the 67th annual meeting of the American Academy of Dermatology, held March 6th through 10th in San Francisco.
Host: Lauren Streicher, MD
Guest: Michael Holick, PhD, MD
It seems these days patients know more about the benefits of Vitamin D than their physicians. Doctors are soaking up the information and making sure their patients are taking the proper levels of Vitamin D. Dr. Michael Holick, professor of medicine, physiology and biophysics and director of the Bone Health Care Clinic and the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center, joins host Dr. Lauren Streicher to discuss the proper dosage, risk factors, geographical factors and benefits of Vitamin D.
Guest: Désirée Ratner, MD
Host: Mary Leuchars, MD
In the next year, nearly 120,000 new cases of melanoma will be diagnosed in the United States, more than half of which will be invasive disease. Unfortunately, trends indicate the overall incidence will continue to rise in the coming years. Who are the key at-risk populations, and how do we identify early warning signs of cancer? Dr. Désirée Ratner, director of dermatologic surgery at Columbia University Medical Center, shares her expertise with host Dr. Mary Leuchars on strategies to recognize early development and initiate treatment of melanoma and nonmelanoma skin cancers.
Guest: Joel Schlessinger, MD
Host: Michael Greenberg, MD
It’s a doctor-certified, non-surgical procedure promising to melt away fat. What is the science behind mesotherapy and lipolysis? Is it safe? Is it effective? Host Dr. Michael Greenberg talks with Dr. Joel Schlessinger, immediate past president of the American Society of Cosmetic Dermatology and Aesthetic Surgery, about these potentially controversial treatment options.
Guest: Mark G. Lebwohl, MD
Host: Michael Greenberg, MD
Dr. Michael Greenberg interviews Dr. Mark Lebwohl, Professor of Dermatology from the Mount Sinai School of Medicine in New York. Dr. Lebwohl discusses Protopic, Elidel, the myths and realities behind their safety for patients.
Guest: Jonathon Moreno, PhD
Host: Maurice Pickard, MD
Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, however, is likely to be slowed due to the denial of federal funds, preventing the institution of guidelines of the National Institute of Health to facilitate the wide and rapid exchange of laboratory discoveries.
Guest: Christopher Miller, MD
Host: Lee Freedman, MD
Dr. Miller reviews basic and newer understandings about melanomas---how do they arise, what are risk factors, how are they recognized and diagnosed?
Guest: Neal Bhatia, MD
Host: Michael Greenberg, MD
Michael Greenberg, M.D. welcomes Neal Bhatia, M.D., Associate Professor of Dermatology at the University of Wisconsin as they discuss dermatology and how primary care physicians can more easily obtain access for their patients.
Guest: Lawrence F. Eichenfield, MD
Host: Andrew Krakowski, MD
Guest: Magdalene Dohil, MD
Join host Dr. Andrew Krakowski as he speaks with Dr. Lawrence Eichenfield and Dr. Magdalene Dohil, of the new Eczema Center at the University of California, San Diego, Rady Children's Hospital. They will be talking about updated diagnostic and treatment approaches for atopic dermatitis in children.
Guest: Jodi Ganz, MD
Host: Larry Kaskel, MD
Dr. Larry Kaskel speaks with Dr. Jodi Ganz from Olansky Dermatology Associates about the burgeoning field of cosmetic dermatology and its increasing impact on several unexpected aspects of men's and women's health.
Guest: Wendy Roberts, MD
Host: Michael Greenberg, MD
Dr. Michael Greenberg speaks with Dr. Wendy Roberts about her involvement with the Women's Dermatologic Society and how the organization is working to support both men and women in the specialty.
Guest: Linda Murray, MD, MPH
Host: Susan Dolan, RN, JD
Join the Chief Medical Officer for the Cook County Department of Public Health in Chicago, Illinois, Dr. Linda Rae Murray, explain how to diagnose and treat itch mite bites.
Host: Andrew Krakowski, MD
Guest: Bari Cunningham, MD
Imagine that you have a rare condition called xeroderma pigmentosum (XP) in which even the slightest amount of UV radiation from the sun turns your skin to cancer. Left untreated, you can expect to die within the first 10 years of your life. Also imagine that your brothers and sisters suffer from this same affliction, but your family lacks the resources to do anything about it. Dr. Bari Cunningham, a pediatric dermatologic surgeon at Rady Children's Hospital of San Diego, journied through the wilderness of Guatemala to a small town where the autosomal recessive disease has dominated the local population and has cast a shadow on life in this simple village. In this segment hear about the fundamentals for the disease process, its prevalence both nationally and globally, and how experts approach XP patients in high- vs low-resource areas. Dr. Andrew Krakowski hosts.
Guest: Bruce Freedman, MD
Host: Leslie P. Lundt, MD
In this segment, Dr. Bruce Freedman gives an overview of dermabrasion and microdermabrasion and the newer procedure or antioxident infusion.
Host: Larry Kaskel, MD
Guest: Elizabeth Tieman, MD
Work-life balance: how many of us can say we have it, let alone come close to having it? Board-certified radiologist Dr. Betsy Tieman is one healthcare professional who can say she achieved work-life balance by leaving private practice where she was working 14 hours a day to take advantage of locum tenens work, which also enabled her to train and compete in triathlons.
Guest: Jodi Ganz, MD
Host: Larry Kaskel, MD
The Skin. What secrets does the largest organ of the body hold?